| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2174dd7ac8f6855b2b6a2019d2e222ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e18b61419ca1f77ccb2b15a5bd837f28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-132 |
| filingDate |
2008-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6528126c2fe044a9573e27f973c6384e |
| publicationDate |
2009-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008139402-A3 |
| titleOfInvention |
A method of inhibiting hiv replication |
| abstract |
This invention relates to compounds and a method for inhibiting or treating HIV infection in a subject. The compounds are activators of AMP-activated protein kinase (AMPK) or pharmaceutically acceptable salts or derivatives of these activators. The activators of AMPK include metformin, metformin hydrochloride and AICAR. |
| priorityDate |
2007-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |